research Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.
Search
for
Sort by
Research
30-60 / 1000+ results 
research Skin Disorders Associated with the COVID-19 Pandemic: A Review
The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.
research Alopecia Areata Occurring After COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.
research Telogen Effluvium After COVID-19 Infection: A Narrative Review of the Physiological Mechanism
COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.
research Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes
COVID-19-related hair loss may have unique features compared to hair loss from other causes.
research Hair Steroid Concentration Before and After the Beginning of the COVID-19 Pandemic in Preschoolers: The Moderating Effect of Family Characteristics
The COVID-19 pandemic did not significantly change stress levels in preschoolers, but higher-income families' children showed higher stress.
research Telogen Effluvium: Long-Term COVID-19 Symptom
COVID-19 recovery can lead to temporary hair loss called telogen effluvium.
research Alopecia Areata as a Sequela of Post-Reinfection COVID-19
COVID-19 reinfection may trigger alopecia areata.
research Evaluation of the Effects of COVID-19 Pandemic on Hair Diseases Through a Web-Based Questionnaire
The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.
research Comparison of Dermatology Diagnoses During COVID-19 Period with Previous Year: What Has Changed?
During the COVID-19 pandemic, some skin conditions became more common while others decreased.
research Pattern Changes of Cutaneous Dermatoses Among Iraqi Women Preceding and During the COVID-19 Pandemic
During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.
research Hair Loss Associated with COVID-19: Problems and Solutions
COVID-19 can cause temporary hair loss due to stress and inflammation.
research Telogen Effluvium: A 360 Degree Review
Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.
research Preliminary Investigation on Microneedling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
The treatment might help COVID-19 related hair loss, but more research is needed.
research Impact of Stem Cell-Based Therapy and Platelet-Rich Plasma in Hair Loss and Telogen Effluvium Related to COVID-19
Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
research A Comment on Psychological Distress and Women’s Hair Loss Related to the COVID-19 Pandemic
The COVID-19 pandemic has increased hair loss and psychological distress in women.
research Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.
research Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study
Women are more likely to have long-term post-COVID symptoms than men.
research Case Report: Hair Care Routine to Treat Telogen Effluvium Associated With Post-COVID-19 Infection
A woman's COVID-19 related hair loss improved after using a specific hair care routine for 30 days.
research Reply to Letter to the Editor: A Response to 'Male Balding Is a Major Risk Factor for Severe COVID-19'
Balding might help identify men at higher risk for severe COVID-19, but more research is needed.
research COVID-19 and Sex Differences: Mechanisms and Biomarkers
Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.
research Burden of Post-COVID-19 Hair Loss Among Older Adults in Vietnam
Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.
research Host Genetic Susceptibility and Impacts of Dietary Factors on COVID-19
Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.
research Testosterone in COVID-19: An Adversary Bane or Comrade Boon
Testosterone's effects on COVID-19 are unclear and need more research.
research COVID-19: Evaluation and Care of Patients With Persistent Symptoms Following Acute SARS-CoV-2 Infection
Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.
research The COVID-19 Pandemic and Its Skin Effects
COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.
research A Case of Telogen Effluvium as COVID Sequelae
A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.
research Rare and Common Manifestations of COVID-19 in Children
COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.
research Global Impact of Coronavirus Disease 2019 (COVID-19)
COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.
research Post-COVID-19 Syndrome: Persistent Symptoms at the Post-Viral Stage of the Disease. A Systematic Review of Current Data
Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.